Cell Metabolism
Author:
Keywords:
Science & Technology, Life Sciences & Biomedicine, Cell Biology, Endocrinology & Metabolism, BRAIN, HYPOXIA, TIGAR, GLUCOSE-6-PHOSPHATE-DEHYDROGENASE, GLUTATHIONE, GLYCOLYSIS, DEFICIENCY, TOLERANCE, CROSSROAD, PATHWAY, Animals, Brain, Brain Ischemia, Carbon, Cellular Reprogramming, Free Radical Scavengers, Gene Deletion, Hydroxylation, Hypoxia-Inducible Factor 1, alpha Subunit, Injections, Intraventricular, Mice, Knockout, Neurons, Neuroprotection, Oligonucleotides, Oxidation-Reduction, Oxygen, Pentose Phosphate Pathway, Phenotype, Procollagen-Proline Dioxygenase, Reactive Oxygen Species, Stroke, 0601 Biochemistry and Cell Biology, 1101 Medical Biochemistry and Metabolomics, 3101 Biochemistry and cell biology, 3205 Medical biochemistry and metabolomics
Abstract:
The oxygen-sensing prolyl hydroxylase domain proteins (PHDs) regulate cellular metabolism, but their role in neuronal metabolism during stroke is unknown. Here we report that PHD1 deficiency provides neuroprotection in a murine model of permanent brain ischemia. This was not due to an increased collateral vessel network. Instead, PHD1(-/-) neurons were protected against oxygen-nutrient deprivation by reprogramming glucose metabolism. Indeed, PHD1(-/-) neurons enhanced glucose flux through the oxidative pentose phosphate pathway by diverting glucose away from glycolysis. As a result, PHD1(-/-) neurons increased their redox buffering capacity to scavenge oxygen radicals in ischemia. Intracerebroventricular injection of PHD1-antisense oligonucleotides reduced the cerebral infarct size and neurological deficits following stroke. These data identify PHD1 as a regulator of neuronal metabolism and a potential therapeutic target in ischemic stroke.